Chertkow, Howard M
$31,625,000.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- April 1, 2019 – March 31, 2024
- Reference
- cihr-irsc:236-2019-2020-Q1-00523
Published purpose
The main objective of CCNA is to advance and apply scientific knowledge to improve health, wellness and quality of services for (a) people at risk of developing neurodegenerative diseases causing dementia, (b) people living with the effects of neurodegenerative diseases affecting cognition and (c) caregivers. Additional objectives of CCNA for Step 2 include: Increasing the interdisciplinary collaborations within and across Teams, Themes and Cross-Cutting Components in the area of age-related neurodegenerative diseases having an impact on cognition, including but not limited to prevention and risk reduction, diagnosis, treatment, care, services, social aspects; Increasing capacity building in the areas of age-related neurodegenerative diseases that have an impact on cognition, including but not limited to prevention and risk reduction, diagnosis, treatment, care, services, social aspects, while integrating sex and gender considerations, Indigenous health perspectives (i.e., First Nations, Inuit and Métis), and persons with lived experience; Enhancing Canadian researchers’ competitiveness, international presence, and influence on outcomes related to neurodegenerative diseases affecting cognition.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.